MS
SYRS

Mizuho Securities’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Mizuho Securities’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-80
Closed -$7K – 171
2019
Q2 		$7K Buy
+80
New +$5.57K 0.01% 141

Other funds holding SYRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Mizuho Securities's SYRS Position: Q3 2019 in Review

Mizuho Securities sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q3 2019, closing a stake of 80 shares — an estimated $7K sold.

Mizuho Securities first reported a position in SYRS in Q2 2019 and held it in 1 quarter. The position peaked at $7K in Q2 2019. 62 funds tracked by Wall St. Rank hold SYRS as of Q3 2019.

  • Mizuho Securities reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Mizuho Securities sold 80 Syros Pharmaceuticals, Inc. Common Stock shares in Q3 2019, an estimated $7K.
  • Mizuho Securities first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Mizuho Securities's Syros Pharmaceuticals, Inc. Common Stock position peaked at $7K in Q2 2019.
  • 62 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on Mizuho Securities's 13F filing for Q3 2019, filed 14 Nov 2019.